Can you explain hypogonadism, its treatment options with rationale, the mechanisms of action of each medication, and the laboratory tests required for monitoring and their interpretation?

Hypogonadism: Comprehensive Overview of Treatment and Monitoring

Hypogonadism requires diagnosis based on both consistent symptoms (decreased libido, erectile dysfunction, reduced muscle mass, fatigue) AND unequivocally low morning total testosterone (<320 ng/dL) or free testosterone (<64 pg/mL) measured on at least two separate occasions. 1

Understanding Hypogonadism

Classification and Clinical Significance

Hypogonadism manifests as inadequate testosterone production and/or impaired spermatogenesis. The classification into primary versus secondary hypogonadism is critical because it fundamentally determines treatment approach and fertility potential 1.

Primary hypogonadism (testicular failure):

• Low testosterone with elevated LH/FSH
• Causes: Klinefelter syndrome, chemotherapy, radiation, trauma, orchitis, HIV, cryptorchidism 1
• Fertility cannot be restored - only donor sperm, adoption, or assisted reproductive technologies are options 1

Secondary hypogonadism (hypothalamic-pituitary dysfunction):

• Low testosterone with low or inappropriately normal LH/FSH
• Causes: Obesity, opioids, glucocorticoids, hyperprolactinemia, pituitary tumors, head trauma, iron overload 1
• Fertility CAN be restored with gonadotropin therapy 1

Functional versus Organic hypogonadism is another crucial distinction 1:

• Functional: Potentially reversible (obesity, medications, systemic illness) - address underlying cause first
• Organic: Permanent structural/congenital damage - requires lifelong treatment

Diagnostic Laboratory Workup

Initial testing (perform between 8-10 AM) 2:

• Morning total testosterone (repeat if low)
• Free testosterone by equilibrium dialysis (especially important in obesity, diabetes, aging, liver disease, thyroid disorders) 1
• Sex hormone-binding globulin (SHBG)

If testosterone is low, measure 2:

• LH and FSH (distinguishes primary from secondary)
• Prolactin (if secondary hypogonadism)
• Iron saturation (hemochromatosis screening)
• Consider pituitary MRI if secondary hypogonadism with low LH/FSH

Laboratory interpretation:

• Total testosterone <320 ng/dL (11 nmol/L) = hypogonadism 1
• Free testosterone <64 pg/mL (220 pmol/L) = hypogonadism 1
• Conditions that lower SHBG (obesity, diabetes, hypothyroidism) can cause falsely low total testosterone with normal free testosterone 1
• Conditions that raise SHBG (aging, HIV, cirrhosis, hyperthyroidism) can cause falsely normal total testosterone with low free testosterone 1

---

Treatment Options: Mechanisms and Rationale

First-Line Approach: Address Reversible Causes

Before initiating testosterone therapy, aggressively manage 3, 1:

• Obesity (weight loss can increase testosterone 1-2 nmol/L) 4
• Discontinue opioids, reduce glucocorticoids if possible 1
• Optimize diabetes control, treat hyperlipidemia
• Tobacco cessation, reduce alcohol 3

This approach is essential because functional hypogonadism may completely reverse, avoiding lifelong medication and preserving fertility 1.

---

Testosterone Replacement Therapy (TRT)

Mechanism of action: Exogenous testosterone binds to androgen receptors throughout the body, directly replacing deficient endogenous production. Testosterone maintains muscle mass and strength; it converts to estradiol (via aromatase) which prevents fat accumulation and maintains bone density; both testosterone and estradiol are required for sexual function 1.

Rationale: TRT is the definitive treatment for organic hypogonadism and symptomatic functional hypogonadism that doesn't respond to lifestyle modification 1.

Transdermal Testosterone (Gels and Patches)

Mechanism: Absorbed through skin, providing steady daily testosterone levels without the peaks/troughs of injections 2.

Rationale for use:

• Preferred first-line option for most patients due to stable levels and convenience 2
• Mimics physiologic testosterone patterns
• Easy dose adjustment

Specific formulations:

• Gels: Apply daily to shoulders/upper arms; dry quickly but risk transfer to others via skin contact 2
• Patches (nonscrotal): Applied nightly to various body sites; may cause skin irritation 3
• Scrotal patches: Higher absorption, but require scrotal shaving; produce elevated DHT levels 3

Monitoring: Check testosterone 2-3 months after initiation, then every 6-12 months once stable 2

Injectable Testosterone

Testosterone enanthate or cypionate (short-acting):

Mechanism: Intramuscular depot slowly releases testosterone over 1-2 weeks 3.

Rationale:

• Most economical option
• Avoids daily administration
• Good for patients with poor adherence or limited resources 2

Dosing:

• Traditional: 200-300 mg every 2-3 weeks (causes significant peaks/troughs) 3
• Preferred: 50-150 mg every 7-14 days for more stable levels 3
• Alternative: 100 mg on days 1,11, and 21 of each month 3

Monitoring: Measure testosterone just before next injection (trough level should be in normal range); check midway between injections 3, 2

Testosterone undecanoate (long-acting):

Mechanism: Very long-acting depot formulation requiring quarterly injections 5.

Rationale: Convenient for patients preferring infrequent dosing 6.

Testosterone Pellets

Mechanism: Subcutaneous implants release testosterone over 3-6 months 3.

Rationale: Longest-acting option, but requires minor surgical procedure for implantation; infrequently used in U.S. 3, 2.

Oral Testosterone

Testosterone undecanoate capsules:

Mechanism: Absorbed through lymphatic system, bypassing first-pass hepatic metabolism 3.

Rationale: Available in Europe but not FDA-approved in U.S.; requires multiple daily doses with erratic absorption 3.

Methyltestosterone: Avoid - associated with hepatotoxicity 3, 6.

---

Alternatives to Testosterone (For Fertility Preservation)

Critical caveat: TRT suppresses the hypothalamic-pituitary-gonadal axis, eliminating sperm production 1, 4. Never use TRT in men desiring fertility.

Gonadotropins (hCG and FSH)

Mechanism: Human chorionic gonadotropin (hCG) mimics LH, stimulating testicular Leydig cells to produce testosterone. FSH stimulates Sertoli cells to support spermatogenesis 4, 7.

Rationale:

• Only option that restores both testosterone AND fertility in secondary hypogonadism 1, 4
• Combined hCG + FSH provides optimal outcomes 4
• Recombinant and urinary-derived formulations equally effective 4

Limitation: Only works in secondary hypogonadism; useless in primary testicular failure 1.

Clomiphene Citrate

Mechanism: Selective estrogen receptor modulator (SERM) that blocks estrogen negative feedback at the hypothalamus/pituitary, increasing LH and FSH secretion, which stimulates testicular testosterone production 6.

Rationale:

• Off-label use for secondary hypogonadism with fertility concerns 6
• Increases endogenous testosterone while preserving spermatogenesis 7
• Safe with good symptom control 7

Best for: Young men with secondary hypogonadism desiring fertility, obese patients 6.

Aromatase Inhibitors

Mechanism: Block conversion of testosterone to estradiol, reducing estrogen-mediated negative feedback, thereby increasing LH/FSH and testosterone production 6.

Rationale:

• Off-label for obese men with high aromatase activity 6
• May benefit patients at high risk for TRT complications 6

Major limitation: Induces osteopenia by blocking estradiol production - estradiol is essential for bone health 7, 6. Use cautiously and monitor bone density.

Nasal Testosterone

Mechanism: Intranasal gel absorbed through nasal mucosa 7.

Rationale: May preserve fertility better than other TRT formulations, but evidence limited to small studies 7.

---

Contraindications to Testosterone Therapy

Absolute contraindications 1, 8:

• Prostate cancer
• Breast cancer
• Desire for fertility in near term
• PSA >4 ng/mL (or >3 ng/mL in high-risk patients without urologic evaluation)
• Untreated severe obstructive sleep apnea
• Uncontrolled heart failure
• Myocardial infarction or stroke within 6 months
• Hematocrit >52%
• Thrombophilia

Relative contraindications 3:

• Benign prostatic hyperplasia with severe symptoms
• Peripheral edema
• Sleep apnea (may worsen)

---

Monitoring During Testosterone Therapy

Pre-Treatment Baseline

Mandatory assessments 3, 1:

• Digital rectal exam
• PSA level
• Hematocrit
• Lipid panel
• Liver function tests

Follow-Up Schedule

First reassessment: 1-3 months after initiation 3, 1:

• Symptom improvement
• Testosterone level (target mid-normal range, 400-700 ng/dL) 9
• Hematocrit (watch for erythrocytosis)
• PSA
• Digital rectal exam

Ongoing monitoring: Every 6-12 months 3, 1, 2:

• Testosterone level
• Hematocrit annually or after dose changes
• PSA and digital rectal exam annually in men >50 years
• Bone density (in selected patients to confirm end-organ response) 5

Laboratory Monitoring Interpretation

Testosterone levels:

• Goal: Mid-normal range (400-700 ng/dL) 9
• Timing depends on formulation (trough for injections, any time for transdermals) 2
• Adjust dose if levels suboptimal or supraphysiologic

Hematocrit:

• Erythrocytosis (hematocrit >54%) is the most common adverse effect 1
• Testosterone stimulates erythropoietin production 8
• If hematocrit >52%, consider dose reduction or therapeutic phlebotomy 3
• Risk increases 8-fold with TRT 1

PSA:

• Baseline PSA required before treatment 3, 1
• Monitor annually in men >50 years 5
• Rapid rise or PSA >4 ng/mL warrants urologic evaluation 1
• Important: No large-scale evidence that TRT causes prostate cancer, but it may accelerate occult cancer 8

Lipids:

• Testosterone may improve HDL and triglycerides 2
• Monitor as part of cardiovascular risk assessment

Bone density:

• Consider in men with osteoporosis or high fracture risk 5
• Testosterone (via conversion to estradiol) improves bone mineral density 1

---

Common Pitfalls and How to Avoid Them

1. Testing testosterone during acute illness or in the afternoon - Always test between 8-10 AM when healthy 1

2. Diagnosing hypogonadism with single testosterone measurement - Require two separate low values 1

3. Ignoring SHBG alterations - Measure free testosterone in obesity, diabetes, liver disease, thyroid disorders 1

4. Starting TRT in men desiring fertility - Use gonadotropins or clomiphene instead 1, 4

5. Not addressing reversible causes first - Weight loss and discontinuing opioids may completely resolve functional hypogonadism 1, 4

6. Inadequate monitoring for erythrocytosis - Check hematocrit regularly; this is the most common complication 1

7. Using aromatase inhibitors long-term without bone density monitoring - These cause osteopenia 7, 6

8. Failing to distinguish primary from secondary hypogonadism - This determines whether fertility can be restored 1